367 related articles for article (PubMed ID: 21885023)
1. [Splenic marginal zone B-cell lymphoma with epidermotropic skin involvement].
Gómez-de la Fuente E; Villalón LB; Calzado-Villarreal L; Pinedo-Moraleda F; López-Estebaranz JL
Actas Dermosifiliogr; 2012 Jun; 103(5):427-31. PubMed ID: 21885023
[TBL] [Abstract][Full Text] [Related]
2. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.
Arcaini L; Paulli M; Boveri E; Vallisa D; Bernuzzi P; Orlandi E; Incardona P; Brusamolino E; Passamonti F; Burcheri S; Schena C; Pascutto C; Cavanna L; Magrini U; Lazzarino M
Cancer; 2004 Jan; 100(1):107-15. PubMed ID: 14692030
[TBL] [Abstract][Full Text] [Related]
3. Marginal zone lymphoma with a dual cutaneous and leukemic presentation and an aberrant myeloid-monocytic phenotype.
Keehn CA; Cualing H
J Cutan Pathol; 2006 Mar; 33(3):236-41. PubMed ID: 16466512
[TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous marginal zone lymphoma with subclinical cutaneous involvement and biclonality.
Edinger JT; Lorenzo CR; Breneman DL; Swerdlow SH
J Cutan Pathol; 2011 Sep; 38(9):724-30. PubMed ID: 21623870
[TBL] [Abstract][Full Text] [Related]
5. Primary nodal marginal zone lymphomas of splenic and MALT type.
Campo E; Miquel R; Krenacs L; Sorbara L; Raffeld M; Jaffe ES
Am J Surg Pathol; 1999 Jan; 23(1):59-68. PubMed ID: 9888704
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous involvement with marginal zone lymphoma.
Gerami P; Wickless SC; Querfeld C; Rosen ST; Kuzel TM; Guitart J
J Am Acad Dermatol; 2010 Jul; 63(1):142-5. PubMed ID: 20462658
[TBL] [Abstract][Full Text] [Related]
7. Primary cutaneous marginal zone lymphoma with sequential development of nodal marginal zone lymphoma in a patient with selective immunoglobulin A deficiency.
Wobser M; Kerstan A; Kneitz H; Goebeler M; Kunzmann V; Rosenwald A; Geissinger E
J Cutan Pathol; 2013 Dec; 40(12):1035-41. PubMed ID: 24274426
[TBL] [Abstract][Full Text] [Related]
8. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ
Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
[TBL] [Abstract][Full Text] [Related]
9. Composite splenic marginal zone lymphoma and classic Hodgkin lymphoma -- an unusual combination.
Elmahy H; Hawley I; Beard J
Int J Lab Hematol; 2007 Dec; 29(6):461-3. PubMed ID: 17988302
[TBL] [Abstract][Full Text] [Related]
10. Myeloid cell nuclear differentiation antigen is expressed in a subset of marginal zone lymphomas and is useful in the differential diagnosis with follicular lymphoma.
Metcalf RA; Monabati A; Vyas M; Roncador G; Gualco G; Bacchi CE; Younes SF; Natkunam Y; Freud AG
Hum Pathol; 2014 Aug; 45(8):1730-6. PubMed ID: 24925224
[TBL] [Abstract][Full Text] [Related]
11. Primary spinal marginal zone lymphoma: case report and review of the literature.
Ahmadi SA; Frank S; Hänggi D; Eicker SO
Neurosurgery; 2012 Aug; 71(2):E495-508; discussion E508. PubMed ID: 22314752
[TBL] [Abstract][Full Text] [Related]
12. Nodal monocytoid B-cell lymphoma (nodal marginal-zone B-cell lymphoma).
Nathwani BN; Drachenberg MR; Hernandez AM; Levine AM; Sheibani K
Semin Hematol; 1999 Apr; 36(2):128-38. PubMed ID: 10319381
[TBL] [Abstract][Full Text] [Related]
13. Clinical presentation and management of marginal zone lymphomas.
Thieblemont C
Hematology Am Soc Hematol Educ Program; 2005; ():307-13. PubMed ID: 16304396
[TBL] [Abstract][Full Text] [Related]
14. Results of bone marrow examination in 275 patients with histological features that suggest an indolent type of cutaneous B-cell lymphoma.
Senff NJ; Kluin-Nelemans HC; Willemze R
Br J Haematol; 2008 Jul; 142(1):52-6. PubMed ID: 18422781
[TBL] [Abstract][Full Text] [Related]
15. Rare presentation of secondary cutaneous involvement by splenic marginal zone lymphoma: report of a case and review of the literature.
Cohen JM; Nazarian RM; Ferry JA; Takvorian RW; Carter JB
Am J Dermatopathol; 2015 Jan; 37(1):e1-4. PubMed ID: 25238446
[TBL] [Abstract][Full Text] [Related]
16. Splenic marginal zone B-cell lymphoma: a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification.
Traverse-Glehen A; Baseggio L; Salles G; Felman P; Berger F
Curr Opin Oncol; 2011 Sep; 23(5):441-8. PubMed ID: 21760505
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow involvement by marginal zone B-cell lymphomas of different types.
Inamdar KV; Medeiros LJ; Jorgensen JL; Amin HM; Schlette EJ
Am J Clin Pathol; 2008 May; 129(5):714-22. PubMed ID: 18426730
[TBL] [Abstract][Full Text] [Related]
18. A case of relapsed disseminated cutaneous MALT lymphoma.
Goodgame BR; Coletti CM; Drees M; Thompson SE
Del Med J; 2011 Dec; 83(12):403-6. PubMed ID: 22458093
[TBL] [Abstract][Full Text] [Related]
19. Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database.
Olszewski AJ; Castillo JJ
Cancer; 2013 Feb; 119(3):629-38. PubMed ID: 22893605
[TBL] [Abstract][Full Text] [Related]
20. Primary gastric follicular lymphoma with parafollicular monocytoid B-cells and lymphoepithelial lesions, mimicking extranodal marginal zone lymphoma of MALT.
Tzankov A; Hittmair A; Müller-Hermelink HK; Rüdiger T; Dirnhofer S
Virchows Arch; 2002 Dec; 441(6):614-7. PubMed ID: 12461620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
